Researchers evaluated the proficiency of Generative Pre-trained Transformer 4 (GPT-4) AI in probabilistic reasoning compared to human clinicians by assessing pretest and posttest probability estimates in diagnostic cases.
FDA Outlines Rules for Telling Clinicians About Unapproved Uses of Drugs, Devices
The FDA has released revised draft guidance on communicating with healthcare professionals (HCPs) about unapproved uses of approved drugs and devices. Once it’s finalized, the